Lacrifill is intended for use in adult patients suffering with dry eyes.1 Lacrifill can potentially benefit a wide range of your patients; from chronic dry eye patients to pre-eye surgery patients.

With Lacrifill you can take control of the ocular surface of your patients, including:

Up to

55%

of patients presenting for refractive surgery have dry eye.2

Addressing DED can maximise the accuracy of your preoperative measurements

DED can disturb keratometry readings, increasing the risk of incorrect selection of intraocular lenses and postoperative refractive error.3-5

When DED is effectively treated before surgery, refractive outcomes are improved.6

Preoperative treatment of DED can help maximise cataract surgical outcomes

Up to 75% of patients scheduled for cataract surgery are reported to suffer from DED preoperatively.7

Unaddressed ocular surface disease can compromise ocular surgery outcomes, leading to unsatisfactory vision, worsening OSD symptoms and patient dissatisfaction.2,8

The ASCRS and ESCRS both recommend perioperative management of dry eye9,10

87%

of cataract surgery patients with DED become symptomatic after surgery, although most patients with pre-existing dry eye are asymptomatic beforehand.11

95%

of patients experience some form of dry eye directly after refractive surgery, and 20-55% report chronic dry eye symptoms (≥6 months).12,13

DED can compromise patient satisfaction after surgery15,17

DED is the most common reason for being ’20/20 unhappy’ after LASIK and cataract surgery14,16

DED can compromise your patients’ recovery after surgery

DED can worsen after cataract surgery, leading to an increased risk of complications and visual changes, including:

  • Disturbed vision26
  • Foreign body sensation, eye fatigue and ocular redness19
  • Impaired healing20

37%

of patients without pre-existing dry eye will develop dry eye after cataract surgery.18

Dry eye signs and symptoms peak in the first month after surgery, but can persist beyond 12 months.18

Chronic dry eye is a self-prepetuating disease with a significant burden on patients21,22

Over

80%

of patients reported that dry eye symptoms interfered with their daily activities, in a real-world survey of nearly 2,000 patients.23

Find out more about how you can take control of your patients ocular surface with Lacrifill

| Lacrifill

Adapted from: Packer M, et al. 2024.

Improvement in dry eye symptoms sustained for 6 months24

Lacrifill® demonstrated significant improvement of symptoms of DED from baseline to month 3 and month 6.

Lacrifill is a treatment your patients can rely on for symptom relief at month 6.

To view the Lacrifill® instructions for use please click here.